108 related articles for article (PubMed ID: 2403452)
1. Proteolytic degradation of human recombinant proinsulin/insulin by sera from acute pancreatitis patients and complete inhibition by Eglin-C.
Lau PP; Van Handel M; Larvin M; McMahon MJ; Geokas MC
Pancreas; 1990; 5(1):17-26. PubMed ID: 2403452
[TBL] [Abstract][Full Text] [Related]
2. Interference of recombinant eglin C, a proteinase inhibitor extracted from leeches, with neutrophil-mediated platelet activation.
Renesto P; Ferrer-Lopez P; Chignard M
Lab Invest; 1990 Apr; 62(4):409-16. PubMed ID: 2159081
[TBL] [Abstract][Full Text] [Related]
3. Amino acids and peptides. XXVIII. Synthesis of peptide fragments related to eglin c and studies on the relationship between their structure and effects on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Tsuboi S; Nakabayashi K; Matsumoto Y; Teno N; Tsuda Y; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2369-76. PubMed ID: 2285973
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
Faller B; Dirrig S; Rabaud M; Bieth JG
Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
[TBL] [Abstract][Full Text] [Related]
5. Serum protease inhibitor capacity for elastase and the severity of pancreatitis.
Kimura T; Ito T; Sumii T; Nawata H
Pancreas; 1992; 7(6):680-5. PubMed ID: 1280365
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
[TBL] [Abstract][Full Text] [Related]
8. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
Steinmeyer J; Kalbhen DA
Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
10. Pathobiochemistry and early CT findings in acute pancreatitis.
Hjelmqvist B; Wattsgård C; Borgström A; Lasson A; Nyman U; Ohlsson K
Digestion; 1989; 44(4):184-90. PubMed ID: 2483691
[TBL] [Abstract][Full Text] [Related]
11. Eglin c, a pharmacologically active elastase inhibitor.
Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Virca GD; Bodmer JL; Snider GL; Lucey EC; Stone PG
Eur J Respir Dis Suppl; 1985; 139():66-70. PubMed ID: 3862612
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and clinical implications of proinsulin conversion intermediates.
Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
[TBL] [Abstract][Full Text] [Related]
13. Digestive enzymes and protease inhibitors in plasma from patients with acute pancreatitis.
Dubick MA; Mar G; Mayer AD; Majumdar AP; McMahon MJ; Geokas MC
Pancreas; 1987; 2(2):187-94. PubMed ID: 2442742
[TBL] [Abstract][Full Text] [Related]
14. Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes.
Yamamoto A; Hayakawa E; Lee VH
Life Sci; 1990; 47(26):2465-74. PubMed ID: 1702176
[TBL] [Abstract][Full Text] [Related]
15. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of the interaction of chymotrypsin with eglin c.
Faller B; Bieth JG
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):27-32. PubMed ID: 1741752
[TBL] [Abstract][Full Text] [Related]
17. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients.
Robbins DC; Shoelson SE; Tager HS; Mead PM; Gaynor DH
Diabetes; 1985 May; 34(5):510-9. PubMed ID: 3886464
[TBL] [Abstract][Full Text] [Related]
18. Amino acids and peptides. XXIX. Synthesis of peptide fragments related to active center of eglin c and studies on the relationship between their structure and their inhibitory activity against cathepsin G and alpha-chymotrypsin.
Nakabayashi K; Tsuboi S; Fujimoto T; Okada Y; Nagamatsu Y; Yamamoto J
Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3249-52. PubMed ID: 2092930
[TBL] [Abstract][Full Text] [Related]
19. Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids.
Kettner CA; Bone R; Agard DA; Bachovchin WW
Biochemistry; 1988 Oct; 27(20):7682-8. PubMed ID: 3207699
[TBL] [Abstract][Full Text] [Related]
20. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S; Sakata M; Beaton AR; Sack RA
Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
